Vitamin Shoppe (VSI) Cut to Hold at ValuEngine

ValuEngine lowered shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a hold rating in a research note released on Sunday.

A number of other research firms also recently weighed in on VSI. Zacks Investment Research raised shares of Vitamin Shoppe from a sell rating to a hold rating in a research note on Wednesday, October 25th. Morgan Stanley reissued an equal weight rating and set a $7.50 target price (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Finally, Barclays lowered their target price on shares of Vitamin Shoppe from $6.00 to $3.00 and set an equal weight rating on the stock in a research report on Thursday, November 9th. Four analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $5.00.

Vitamin Shoppe (NYSE:VSI) opened at $4.40 on Friday. Vitamin Shoppe has a one year low of $2.95 and a one year high of $24.85. The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59. The firm has a market cap of $105.50, a price-to-earnings ratio of -0.42 and a beta of 0.69.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The company had revenue of $288.20 million during the quarter, compared to analyst estimates of $297.61 million. During the same period last year, the company posted $0.50 earnings per share. The company’s revenue was down 8.5% compared to the same quarter last year. research analysts predict that Vitamin Shoppe will post 0.34 EPS for the current fiscal year.

A number of institutional investors have recently bought and sold shares of VSI. Russell Investments Group Ltd. increased its position in Vitamin Shoppe by 16.7% during the second quarter. Russell Investments Group Ltd. now owns 26,788 shares of the specialty retailer’s stock worth $312,000 after buying an additional 3,839 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its position in Vitamin Shoppe by 18.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after buying an additional 1,440 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in Vitamin Shoppe by 34.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock worth $3,054,000 after buying an additional 67,362 shares during the last quarter. Arizona State Retirement System increased its position in Vitamin Shoppe by 0.8% during the second quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock worth $145,000 after buying an additional 100 shares during the last quarter. Finally, Legal & General Group Plc increased its position in Vitamin Shoppe by 9.3% during the second quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock worth $518,000 after buying an additional 3,789 shares during the last quarter. 90.35% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Vitamin Shoppe (VSI) Cut to Hold at ValuEngine” was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.chaffeybreeze.com/2018/01/03/vitamin-shoppe-vsi-cut-to-hold-at-valuengine.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply